During the past decade, Psoriasis Treatment Center of South Florida conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Psoriasis Treatment Center of South Florida" #1 collaborator was "Hexal AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Psoriasis Treatment Center of South Florida" are "Hand Eczema" (1 trials) and "Plaque Type Psoriasis" (1 trials). Many other conditions were trialed in "Psoriasis Treatment Center of South Florida" in a lesser frequency.

Most popular intervention types in "Psoriasis Treatment Center of South Florida" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "GP2017 Adalimumab" (1 trials), "Humira ® Adalimumab" (1 trials), "Ruxolitinib cream" (1 trials) and "Vehicle" (1 trials). Other intervention names were less common.

The vast majority of trials in "Psoriasis Treatment Center of South Florida" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Psoriasis Treatment Center of South Florida". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Psoriasis Treatment Center of South Florida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Psoriasis Treatment Center of South Florida, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".